Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease.

At 24 months, our study found that patients with predominantly advanced infra-popliteal PAD who were treated with Absorb bioresorbable vascular scaffold reported improved clinical status and a low and durable rate of clinically driven target vessel failure extending out to 24 months.